Search Results - "He, Yanglan"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    The signatures and crosstalk of gut microbiome, mycobiome, and metabolites in decompensated cirrhotic patients by Li, Yangjie, Liu, Danping, He, Yanglan, Zhang, Zeming, Zeng, Ajuan, Fan, Chunlei, Lyu, Lingna, He, Zilong, Ding, Huiguo

    Published in Frontiers in microbiology (21-08-2024)
    “…Numerous studies have confirmed that gut microbiota plays a crucial role in the progression of cirrhosis. However, the contribution of gut fungi in cirrhosis…”
    Get full text
    Journal Article
  2. 2

    Association of thromboelastography profile with severity of liver cirrhosis and portal venous system thrombosis by He, Yanglan, Yuan, Shanshan, Guo, Xiaozhong, Yi, Fangfang, Xu, Xiangbo, An, Yang, Xu, Shixue, Ageno, Walter, Qi, Xingshun

    Published in BMC gastroenterology (07-06-2021)
    “…Hemostasis profile is often complicated in liver cirrhosis. Thromboelastography is a global viscoelastic test recommended by the current practice guideline and…”
    Get full text
    Journal Article
  3. 3

    Computed Tomography Images of Spontaneous Portosystemic Shunt in Liver Cirrhosis by Yi, Fangfang, Guo, Xiaozhong, Zeng, Qing-Lei, Yang, Benqiang, He, Yanglan, Yuan, Shanshan, Arora, Ankur, Qi, Xingshun

    “…Spontaneous portosystemic shunt (SPSS) refers to collateral vessels that communicate between the portal vein system and systemic circulation. SPSS mainly…”
    Get full text
    Journal Article
  4. 4

    Auxilin‐like protein MoSwa2 promotes effector secretion and virulence as a clathrin uncoating factor in the rice blast fungus Magnaporthe oryzae by Liu, Muxing, Hu, Jiexiong, Zhang, Ao, Dai, Ying, Chen, Weizhong, He, Yanglan, Zhang, Haifeng, Zheng, Xiaobo, Zhang, Zhengguang

    Published in The New phytologist (01-04-2021)
    “…Summary Plant pathogens exploit the extracellular matrix (ECM) to inhibit host immunity during their interactions with the host. The formation of ECM involves…”
    Get full text
    Journal Article
  5. 5

    Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis by Xu, Shixue, Guo, Xiaozhong, Xu, Xiangbo, Wang, Le, Tacke, Frank, Primignani, Massimo, He, Yanglan, Yin, Yue, Yi, Fangfang, Qi, Xingshun

    “…Portal venous system thrombosis (PVST) will progress in some cases, indicating worse outcome and the necessity of antithrombotic treatment, but will…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Review article: thromboelastography in liver diseases by He, Yanglan, Yao, Haijuan, Ageno, Walter, Méndez‐Sánchez, Nahum, Guo, Xiaozhong, Qi, Xingshun

    Published in Alimentary pharmacology & therapeutics (01-08-2022)
    “…Summary Background Patients with liver diseases have complicated haemostatic alternations, resulting in both bleeding and thromboembolic complications, which…”
    Get full text
    Journal Article
  8. 8

    Auxilin‐like protein MoSwa2 promotes effector secretion and virulence as a clathrin uncoating factor in the rice blast fungus Magnaporthe o ryzae by Liu, Muxing, Hu, Jiexiong, Zhang, Ao, Dai, Ying, Chen, Weizhong, He, Yanglan, Zhang, Haifeng, Zheng, Xiaobo, Zhang, Zhengguang

    Published in The New phytologist (13-02-2021)
    “…Plant pathogens exploit the extracellular matrix (ECM) to inhibit host immunity during their interactions with the host. The formation of ECM involves a series…”
    Get full text
    Journal Article
  9. 9

    Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study by Xu, Xiangbo, Xu, Shixue, Primignani, Massimo, De Stefano, Valerio, He, Yanglan, Yi, Fangfang, Guo, Xiaozhong, Valla, Dominique, Qi, Xingshun

    Published in Advances in therapy (01-04-2020)
    “…Introduction Occlusive portal venous system thrombosis (PVT) is significantly associated with poor outcomes in cirrhotic patients. Nonselective β-blockers…”
    Get full text
    Journal Article
  10. 10
  11. 11